Get started
000

DAIHAN PHARMACEUTICAL

No trades
See on Supercharts
Overview
Financials Discussions Technicals Forecast Seasonals

023910 chart


Full chart

Key stats


Market capitalization
‪152.40 B‬ KRW
Dividend yield (indicated)
2.95%
Price to earnings Ratio (TTM)
0
Basic EPS (TTM)
5,100 KRW
Net income (FY)
‪28.43 B‬ KRW
Revenue (FY)
‪195.91 B‬ KRW
Shares float
‪3.59 M‬
Beta (1Y)
0.22

Employees


Employees (FY)
708
Change (1Y)
+17 +2.46%
Revenue / Employee (1Y)
‪212.51 K‬ KRW
Net income / Employee (1Y)
‪30.84 K‬ KRW

About DAIHAN PHARMACEUTICAL


Sector
Health Technology
Industry
Medical Specialties
CEO
Yoon-Woo Lee
Website
daihan.com
Headquarters
Seoul
Founded
1945
ISIN
KR7023910003
FIGI
BBG000C1MB31
Daihan Pharmaceutical Co., Ltd. engages in the manufacture and sale of medical products. The company operates through Pharmaceutical products and Other. Its main products include sap ample and contract research services. The company was founded by In-Sil Lee in 1945 and is headquartered in Seoul, South Korea.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 023910 is 25,400 KRW — it hasn't changed in the past 24 hours. Watch DAIHAN PHARMACEUTICAL stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange DAIHAN PHARMACEUTICAL stocks are traded under the ticker 023910.
023910 stock has risen by 1.40% compared to the previous week, the month change is a −3.42% fall, over the last year DAIHAN PHARMACEUTICAL has showed a −5.93% decrease.
We've gathered analysts' opinions on DAIHAN PHARMACEUTICAL future price: according to them, 023910 price has a max estimate of 40,000.00 KRW and a min estimate of 40,000.00 KRW. Watch 023910 chart and read a more detailed DAIHAN PHARMACEUTICAL stock forecast: see what analysts think of DAIHAN PHARMACEUTICAL and suggest that you do with its stocks.
023910 reached its all-time high on Jan 15, 2018 with the price of 52,700 KRW, and its all-time low was 1,050 KRW and was reached on Oct 28, 2008. View more price dynamics on 023910 chart.
See other stocks reaching their highest and lowest prices.
023910 stock is 0.59% volatile and has beta coefficient of 0.22. Track DAIHAN PHARMACEUTICAL stock price on the chart and check out the list of the most volatile stocks — is DAIHAN PHARMACEUTICAL there?
Yes, you can track DAIHAN PHARMACEUTICAL financials in yearly and quarterly reports right on TradingView.
DAIHAN PHARMACEUTICAL revenue for the last quarter amounts to ‪48.90 B‬ KRW, despite the estimated figure of ‪52.30 B‬ KRW. In the next quarter, revenue is expected to reach ‪51.30 B‬ KRW.
023910 net income for the last quarter is ‪8.02 B‬ KRW, while the quarter before that showed ‪8.27 B‬ KRW of net income which accounts for −3.00% change. Track more DAIHAN PHARMACEUTICAL financial stats to get the full picture.
Yes, 023910 dividends are paid annually. The last dividend per share was 750.00 KRW. As of today, Dividend Yield (TTM)% is 2.95%. Tracking DAIHAN PHARMACEUTICAL dividends might help you take more informed decisions.
DAIHAN PHARMACEUTICAL dividend yield was 2.70% in 2023, and payout ratio reached 15.51%. The year before the numbers were 2.12% and 15.59% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 8, 2024, the company has 708.00 employees. See our rating of the largest employees — is DAIHAN PHARMACEUTICAL on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DAIHAN PHARMACEUTICAL EBITDA is ‪44.06 B‬ KRW, and current EBITDA margin is 22.69%. See more stats in DAIHAN PHARMACEUTICAL financial statements.
Like other stocks, 023910 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DAIHAN PHARMACEUTICAL stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DAIHAN PHARMACEUTICAL technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DAIHAN PHARMACEUTICAL stock shows the sell signal. See more of DAIHAN PHARMACEUTICAL technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.